Metabolic reprogramming: A novel therapeutic target in diabetic kidney diseaseMengdi Wang, Wenjing Zhao, Mengchao Liu et al.|Frontiers in Pharmacology|2022Cited by 41
BaoShenTongLuo formula protects against podocyte injury by regulating AMPK-mediated mitochondrial biogenesis in diabetic kidney diseaseYifan Guo, Wenjing Zhao, Mengdi Wang et al.|Chinese Medicine|2023Cited by 15
BaoShenTongLuo formula protects against podocyte injury by regulating AMPK-mediated mitochondrial biogenesis in diabetic kidney disease.Yifan Guo, Wenjing Zhao, Zhen Cai et al.|Research Square|2023Cited by 1